CXCL9 and neoplasm: This macrophage population is reprogrammed by the IFN-I signaling transmitted from tumor cells, leading to increased expression of T cell chemokine CXCL9/XCL10 and upregulation of the antigen-presenting machinery, thereby boosting CD8+ T cell–mediated antitumor immunity.